Status:
COMPLETED
Application of Ergogenic Aids to the Prehabilitation of Abdominal Cancer Patients Undergoing Cancer Surgery
Lead Sponsor:
University of Texas at Austin
Conditions:
Prehabilitation
Eligibility:
All Genders
18-90 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of the proposed study is to measure surgical recovery, including the length of hospital stay, incidence of perioperative complications, and mortality at 90 days post-surgery, in surgical p...
Detailed Description
The investigators propose that steps to augment and optimize the effectiveness of prehabilitation interventions for abdominal cancer patients may be found in the field of sport science. The investigat...
Eligibility Criteria
Inclusion
- Patients certified by a surgeon to participate in this study;
- Patients between the ages of 18 and 90;
- Patients with GI cancer.
Exclusion
- Patients with
- Uncontrolled or active angina;
- New York Heart Association Class 3 or 4 heart failure;
- A myocardial infarction within the last 6 months;
- Severe/ uncontrolled hypertension (systolic pressure ≥180 mmHg or diastolic pressure ≥120mmHg);
- Uncontrolled diabetes (fasting blood glucose \>400 mg/dL);
- American Society of Anesthesiologists (ASA) health status grade IV-V.
- Severe orthopedic conditions that prohibit or impede exercise;
- Wheelchair dependence;
- Co-morbid medical conditions interfering with the ability to perform exercise; -Severely impaired ambulation (i.e. patients with uncontrolled neuromuscular disorders);
- History of Acute Deep Venous Thrombosis within the last 6 months;
- Inability to comply with exercise instructions upon evaluation; or
- Inability to provide an informed consent (dementia);
- Taking medication/supplements containing nitrites/nitrates;
- With allergies to creatine monohydrate;
- With allergies or intolerance to artificial sweeteners such as Sucralose, Xylitol, Aspartame, or Stevia;
- Simultaneous participation in a pharmacotherapy trial;
- Estimated glomerular filtration rate (EGFR) \< 30 and not currently on dialysis.
- Pregnant or lactating women
- Dementia
- Mini Mental State Examination score of Severe Impairment (≤17), or
- Patients with severe depression.
Key Trial Info
Start Date :
October 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2020
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT04073381
Start Date
October 28 2018
End Date
August 31 2020
Last Update
July 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiovascular Aging Research Laboratory at UT Austin
Austin, Texas, United States, 78712